Location History:
- San Diego, CA (US) (2014)
- Del Mar, CA (US) (2010 - 2023)
Company Filing History:
27 out of 2,285 
1 out of 1 
2 out of 832,761 Years Active: 2010-2023
Title: Andrew M. Blumenfeld: Innovator in Neurotoxin Therapies
Introduction
Andrew M. Blumenfeld, based in Del Mar, California, is a prolific inventor holding 28 patents. His groundbreaking work primarily focuses on neurotoxin compositions and their applications in medical treatments, particularly for headaches and psychological trauma.
Latest Patents
Among his latest patents are innovative compositions aimed at addressing significant health issues. The first patent, "Neurotoxin compositions for use in treating headache," outlines novel methods and formulations for alleviating headache pain. Another significant contribution is titled "Treatment of psychological trauma," which discloses methods involving botulinum toxins and targeted exocytosis modulators to address psychological trauma in individuals, showcasing his focus on leveraging biotechnology for therapeutic advancements.
Career Highlights
Andrew's extensive career includes impactful tenures at renowned companies, including Allergan, Inc. His commitment to innovation in the medical field has led to numerous advancements in treatment methodologies that have the potential to improve countless lives.
Collaborations
Throughout his career, Andrew has collaborated with esteemed colleagues such as Mitchell F. Brin and Franklin D. Gaylis. These partnerships have undoubtedly enhanced the depth and breadth of his research and patents, driving forward the field of neurotoxicology.
Conclusion
Andrew M. Blumenfeld stands out as a significant figure in the world of medical innovation. With a robust portfolio of patents and strategic collaborations, he continues to make remarkable contributions that enhance our understanding and treatment of neurological and psychological conditions. His work exemplifies the transformative power of innovation in medicine.